Vasoactive intestinal peptide (VIP) induces c-fos expression in LNCaP prostate cancer cells through a mechanism that involves Ca2+ signalling. Implications in angiogenesis and neuroendocrine differentiation. [electronic resource]
Producer: 20050729Description: 224-33 p. digitalISSN:- 0006-3002
- Calcium -- metabolism
- Calcium Signaling -- drug effects
- Cell Differentiation -- drug effects
- Cell Line, Tumor
- Chelating Agents -- pharmacology
- Cyclic AMP -- metabolism
- Drug Interactions
- Egtazic Acid -- analogs & derivatives
- Gene Expression Regulation -- drug effects
- Humans
- Isoquinolines -- pharmacology
- Male
- Neuropeptides -- metabolism
- Prostatic Neoplasms
- Proto-Oncogene Proteins c-fos -- drug effects
- RNA, Messenger -- drug effects
- Sulfonamides -- pharmacology
- Vascular Endothelial Growth Factor A -- metabolism
- Vasoactive Intestinal Peptide -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.